Publications
Peer-Reviewed Publications: 172
h-index: 38 (WoS), 42 (Google Scholar)
(15-11-2023)
172.- D. Beirne, B. Farkas, C. Donati, V. Gandin, I. Rozas, T. Velasco-Torrijos, D. Montagner. "Novel design of dual-action Pt(IV) anticancer pro-drugs based on cisplatin and derivatives of the Tyrosine Kinase Inhibitors imatinib and nilotinib". Dalton Trans., 14110-14122, 52 (2023). DOI: 10.1039/d3dt02030d.
171.- B. Farkaš, M. Minneci, M. Misevicius, I. Rozas. " A Tale of Two Proteases: MPro and TMPRSS2 as Targets forCOVID-19 Therapies". Pharmaceuticals, 834, 16 (2023). DOI: 10.3390/ph16060834.
170.- M. Minneci, M. Misevicius, I. Rozas. "Green Synthesis of Nitroaryl Thioureas: Towards an Improved Preparation of Guanidinium DNA Binders". Bioorg. Med. Chem. Lett., 129346, 90 (2023). DOI: 10.1016/j.bmcl.2023.129346
169.- M. R. Garcia, I. Iribarren, I. Rozas, C. Trujillo. "Simultaneous Hydrogen Bonds with Different Binding Modes: the Acceptor “Rules” but the Donor “Chooses”". Chem. Eur. J., e20223577, 29 (2023). DOI: 10.1002/chem.202203577.
168.- N. Stipaničev, K. Raabe, I. Rozas. "Aiming to Improve Binding of Porphyrin Diphenyl Guanidinium Conjugates to Guanine-Quadruplexes: When Size Matters". Bioorg. Med. Chem. Lett., 128954, 75 (2022). DOI: 10.1016/j.bmcl.2022.128954.
167.- F. Prencipe, A. Alsibaee, Z. Khaddem, P. Norton, A.M. Towell, A.F.M. Ali, G. Reid, O.M. Fleury, T.J. Foster, J.A. Geoghegan, I. Rozas, M.P. Brennan. "Allantodapsone is a pan-inhibitor of Staphylococcus aureus adhesion to fibrinogen, loricrin and cytokeratin 10". Microbiol. Spectr., e0117521 (2022). DOI: 10.1128/spectrum.01175-21.
166.- M.C. Costas-Lago, N. Vila, A. Rahman, P. Besada, I. Rozas, J. Brea, M. Loza, E. González-Romero, C. Terán. "Novel pyridazin-3(2H)-one-based guanidine derivatives as potential DNA minor groove binders with anticancer activity". ACS Med. Chem. Lett., 463, 13 (2022). DOI: 10.1021/acsmedchemlett.1c00633.
165.- R. Amet, V. Previtali, H. B. Mihigo, E. Sheridan, S. Brophy, N. K. Hante, M. J. Santos-Martinez, P. J. Hayden, P. V. Browne, I. Rozas, A. M. McElligott, D. M. Zisterer. "A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma". Life Sciences, 120236, 290 (2022). DOI: 10.1016/j.lfs.2021.120236
164.- R. Chari, I. Rozas. Virus, Antivirals and Vaccines: Why Politics Matter. In Viral Politics, Eds. R. Chari and I. Rozas. DeGruyter. 2021. ISSN: 2747-6863. DOI: 10.0000/9783110743609.